CONTENTS:
- Contingency management treatments: controversies and challenges, Petry N. M., p. 1507-1509.
- Continuities and changes in self-change research, Klingemann H., Sobell M. B., Sobell L. C., p. 1510-1518.
- Towards a self-change-friendly treatment and policy for addictive behaviours, Hao W., Tan L., Tang Q., p. 1519-1520; discussion 1524.
- Why is natural recovery so common for addictive disorders?, Slutske W. S., p. 1520-1521; discussion 1524.
- What do marshmallows and golf tell us about natural recovery research?, Miller P. M., Smith J. P., p. 1521-1522; discussion 1524.
- What does self-change mean for how we deliver treatment?, Teesson M., p. 1522-1523; discussion 1524.
- Addiction research centres and the nurturing of creativity. The Chinese National Institute on Drug Dependence, Peking University: past, present and future, Wang X., Zhao D., Shi J., Zhao C., Liu Z., Lu L., p. 1525-1530.
- The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective, Bell J., p. 1531-1537.
- Anti-drink driving reform in Britain, c. 1920-80, Luckin B., p. 1538-1544.
- Meta-analysis of drug-related deaths soon after release from prison, Merrall E. L., Kariminia A., Binswanger I. A., Hobbs M. S., Farrell M., Marsden J., et al., p. 1545-1554.
- Using the internet to research hidden populations of illicit drug users: a review, Miller P. G., Sonderlund A. L., p. 1557-1567.
- Should symptom frequency be factored into scalar measures of alcohol use disorder severity?, Dawson D. A., Grant B. F., p. 1568-1579.
- Alcohol, suppressed anger and violence, Norstrom T., Pape H., p. 1580-1586.
- US state alcohol sales compared to survey data, 1993-2006, Nelson D. E., Naimi T. S., Brewer R. D., Roeber J., p. 1589-1596.
- Behavioral economic analysis of cue-elicited craving for alcohol, Mackillop J., O'hagen S., Lisman S. A., Murphy J. G., Ray L. A., Tidey J. W., et al., p. 1599-1607.
- The influence of cultural orientation, alcohol expectancies and self-efficacy on adolescent drinking behavior in Beijing, Shell D. F., Newman I. M., Xiaoyi F., p. 1608-1615.
- Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial, Polsky D., Glick H. A., Yang J., Subramaniam G. A., Poole S. A., Woody G. E., p. 1616-1624.
- Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?, Romelsjo A., Engdahl B., Stenbacka M., Fugelstad A., Davstad I., Leifman A., et al., p. 1625-1632.
- Challenges to antagonist blockade during sustained-release naltrexone treatment, Kunoe N., Lobmaier P., Vederhus J. K., Hjerkinn B., Gossop M., Hegstad S., et al., p. 1633-1639.
- The impact of eliminating the global illicit cigarette trade on health and revenue, Joossens L., Merriman D., Ross H., Raw M., p. 1640-1649.
- Association of adolescent symptoms of depression and anxiety with daily smoking and nicotine dependence in young adulthood: findings from a 10-year longitudinal study, Mckenzie M., Olsson C. A., Jorm A. F., Romaniuk H., Patton G. C., p. 1652-1659.
- Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy, Killen J. D., Fortmann S. P., Murphy G. M., Jr., Hayward C., Fong D., Lowenthal K., et al., p. 1660-1668.
- Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility, Fishman M. J., Winstanley E. L., Curran E., Garrett S., Subramaniam G., p. 1669-1676.